Securities and Exchange Commission in accordance with the Notification of the Capital Market Supervisory Board No. TorChor. 72/2558, Re: Approval of Offering for Sale of Newly Issue Shares by Listed Companies
resolutions on the important agenda of the Board of Directors Meeting of the Company No. 5/2017, held on 7 November 2017, as follows: 1. Resolved for approval of the submission to the Shareholders’ meeting for
which has similar supervision to that of the Office; (6) “Company” means any limited company or public limited company; (7) “Holding company” means any company undertaking core business in holding shares
undertaking core business in holding shares of other companies with a purpose to gain control in such companies rather than to invest for ordinary returns; (8) “Subsidiary company” means (a) Any company whose
shares in Thai Japan Laboratories Co., Ltd.) The information above is the exemption and no need to get approval from the shareholders. According to the announcement No. Tor.Jor.21/2551 in the subject of
9 9. Source of Investment Capital The source of funding for the acquisition of ordinary shares of COMASS will come from the Company’s working capital and loan granted from a financial institution. In
”) (JAS is a shareholder of the Company directly holding 32.80 percent of shares in the Company, and indirectly holding 9.06 percent of the shares in the Company through ACeS Regional Services Co., Ltd